S3V Vascular Technologies raises INR 300 crore for a US-FDA approved neurovascular device manufacturing plant and expansion.

Medical devices firm S3V Vascular Technologies raises INR 300 crore from investors including A.M. Naik and Madhusudan Kela for a US-FDA approved manufacturing plant that will produce next-generation neurovascular medical devices. The funds will also be used for sales, marketing, and securing US-FDA approval. The company's focus is on creating devices to combat the rise of strokes in India.